Assignee
SANGART INC
US11 patents
Top patents by PatentIndex Score
US6844317B2Jan 18, 2005
Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin
SANGART INC53 citations95
US7625862B2Dec 1, 2009
Method for making a high oxygen affinity modified hemoglobin for oxygen transport
SANGART INC14 citations92
US6974795B2Dec 13, 2005
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
SANGART INC29 citations92
US6773613B1Aug 10, 2004
Method for production of stroma-free hemoglobin
SANGART INC25 citations92
US8377868B2Feb 19, 2013
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
SANGART INC7 citations83
US7989414B2Aug 2, 2011
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
SANGART INC10 citations83
US7271145B2Sep 18, 2007
Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
SANGART INC9 citations73
US7622439B2Nov 24, 2009
Method to enhance hemodynamic stability using oxygen carrying compositions
SANGART INC2 citations62
US10821158B2Nov 3, 2020
Polyalkylene oxide valerate hemoglobin conjugates
SANGART INC1 citations58
US8021858B2Sep 20, 2011
Method for making polyalkylene oxide modified hemoglobin
SANGART INC4 citations53
US9174771B2Nov 3, 2015
Packaging system for preserving a nonoxygenated hemoglobin based oxygen therapeutic product
SANGART INC0 citations32